Drug
Tasquinimod clinical trials
Also written ABR-215050.
- studies test it
- 10
- open now
- 1
- in phase 3
- 2
- first study started
- 2007
Keep track of what changes. Save the tasquinimod studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
10 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 5
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 4
Ipsen (3) · Active Biotech AB (3) · Roswell Park Cancer Institute (1) · Andrew J. Armstrong, MD (1) · Stichting Hemato-Oncologie voor Volwassenen Nederland (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
Studies
Open first, then newest update. How each study uses tasquinimod is read from its arms, and is right about nine times in ten.
Testing it · 10
- Tasquinimod in Patients with Myelofibrosis Refractory to or Intolerant for JAK2 InhibitionRecruitingPhase 1/2Stichting Hemato-Oncologie voor Volwassenen NederlandNCT06605586Written as Tasquinimod
- Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedPhase 2Roswell Park Cancer InstituteNCT02159950Written as Tasquinimod
- Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate CancerTerminatedPhase 3IpsenNCT02057666Written as Tasquinimod
- A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based ChemotherapyTerminatedPhase 2IpsenNCT01732549Written as Tasquinimod
- A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric CancersCompletedPhase 2IpsenNCT01743469Written as Tasquinimod
- The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate CancerCompletedPhase 1Andrew J. Armstrong, MDNCT01513733Written as tasquinimod
- A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate CancerWithdrawnPhase 1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT02396368Written as Tasquinimod
- Efficacy Study of ABR-215050 to Treat Prostate CancerCompletedPhase 2Active Biotech ABNCT00560482Written as ABR-215050, tasquinimod
- A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate CancerCompletedPhase 3Active Biotech ABNCT01234311Written as tasquinimod
- A Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy SubjectsCompletedPhase 1Active Biotech ABNCT01048203Written as ABR-215050
Given in every arm · 2 — tasquinimod is usual care beside what is tested
- Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)RecruitingPhase 1/2M.D. Anderson Cancer CenterNCT06327100Written as Tasquinimod
- Tasquinimod for the Treatment of Relapsed or Refractory MyelomaTerminatedPhase 1University of PennsylvaniaNCT04405167Written as Tasquinimod
Codes
What other systems call tasquinimod · ClinicalTrials.gg INT005019
- MeSH (NLM) C516109tasquinimodConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 756U07KN1RTASQUINIMODConfirmed FDA, NLM, Wikidata
- Wikidata Q7687612tasquinimodConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C74080TasquinimodOne source FDA
- DrugBank DB05861One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C516109 | tasquinimod | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 756U07KN1R | TASQUINIMOD | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7687612 | tasquinimod | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C74080 | Tasquinimod | One source FDA |
| DrugBank | DB05861 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.